Work

Comparative cost-utility analysis of ixekizumab, tofacitinib, and golimumab in psoriatic arthritis: a real-world Markov model simulation

Year: 2026

Type: article

Source: Expert Review of Pharmacoeconomics & Outcomes Research

DOI: 10.1080/14737167.2026.2629351

Authors: Rubén Queiro, Ignacio Braña, Paula Alvarez, Marta Loredo, Estefanía Pardo, Stefanie Burger

Institutions: Universidad de Oviedo, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128374830

FWCI:

Cites: 29

Cited by:

Related to: